3002
Use of Cytokine Inhibitors in Severe Asthma
Sunday, March 2, 2014: 7:00 AM-8:00 AM
Marriott South Tower, Level 3, Marina Ballroom Salon E
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Jonathan Corren , MD
Sally E. Wenzel , MD FAAAAI
Learning Objectives:
  1. Review and understand the roles that specific cytokines play in asthma
  2. Review trials of various agents (anti-TNF, anti-IL4, anti-IL13, anti-IL5, anti-IL17, anti-IL9) if asthma
  3. Explore subtypes of asthma where these agents might best be used
See more of: Seminar